Links to Exploration step
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Triumphs, trials, and tribulations of the global response to MERS coronavirus</title><author><name sortKey="Mcnabb, Scott J N" sort="Mcnabb, Scott J N" uniqKey="Mcnabb S" first="Scott J N" last="Mcnabb">Scott J N. Mcnabb</name><affiliation><nlm:aff id="aff1">Rollins School of Public Health, Atlanta, GA 30322, USA</nlm:aff></affiliation></author><author><name sortKey="Shaikh, Affan T" sort="Shaikh, Affan T" uniqKey="Shaikh A" first="Affan T" last="Shaikh">Affan T. Shaikh</name><affiliation><nlm:aff id="aff2">Public Health Practice, LLC, Atlanta, GA, USA</nlm:aff></affiliation><affiliation><nlm:aff id="aff3">Ministry of Health, Riyadh, Saudi Arabia</nlm:aff></affiliation></author><author><name sortKey="Nuzzo, Jennifer B" sort="Nuzzo, Jennifer B" uniqKey="Nuzzo J" first="Jennifer B" last="Nuzzo">Jennifer B. Nuzzo</name><affiliation><nlm:aff id="aff4">UPMC Center for Health Security, Baltimore, MD, USA</nlm:aff></affiliation></author><author><name sortKey="Zumla, Alimuddin I" sort="Zumla, Alimuddin I" uniqKey="Zumla A" first="Alimuddin I" last="Zumla">Alimuddin I. Zumla</name><affiliation><nlm:aff id="aff5">Division of Infection and Immunity, University College London, London, UK</nlm:aff></affiliation><affiliation><nlm:aff id="aff6">NIHR Biomedical Research Centre, University College London Hospitals, London, UK</nlm:aff></affiliation></author><author><name sortKey="Heymann, David L" sort="Heymann, David L" uniqKey="Heymann D" first="David L" last="Heymann">David L. Heymann</name><affiliation><nlm:aff id="aff7">Centre on Global Health Security, Chatham House, London, UK</nlm:aff></affiliation><affiliation><nlm:aff id="aff8">Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK</nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">24794576</idno><idno type="pmc">7129523</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129523</idno><idno type="RBID">PMC:7129523</idno><idno type="doi">10.1016/S2213-2600(14)70102-X</idno><date when="2014">2014</date><idno type="wicri:Area/Pmc/Corpus">000807</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000807</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Triumphs, trials, and tribulations of the global response to MERS coronavirus</title><author><name sortKey="Mcnabb, Scott J N" sort="Mcnabb, Scott J N" uniqKey="Mcnabb S" first="Scott J N" last="Mcnabb">Scott J N. Mcnabb</name><affiliation><nlm:aff id="aff1">Rollins School of Public Health, Atlanta, GA 30322, USA</nlm:aff></affiliation></author><author><name sortKey="Shaikh, Affan T" sort="Shaikh, Affan T" uniqKey="Shaikh A" first="Affan T" last="Shaikh">Affan T. Shaikh</name><affiliation><nlm:aff id="aff2">Public Health Practice, LLC, Atlanta, GA, USA</nlm:aff></affiliation><affiliation><nlm:aff id="aff3">Ministry of Health, Riyadh, Saudi Arabia</nlm:aff></affiliation></author><author><name sortKey="Nuzzo, Jennifer B" sort="Nuzzo, Jennifer B" uniqKey="Nuzzo J" first="Jennifer B" last="Nuzzo">Jennifer B. Nuzzo</name><affiliation><nlm:aff id="aff4">UPMC Center for Health Security, Baltimore, MD, USA</nlm:aff></affiliation></author><author><name sortKey="Zumla, Alimuddin I" sort="Zumla, Alimuddin I" uniqKey="Zumla A" first="Alimuddin I" last="Zumla">Alimuddin I. Zumla</name><affiliation><nlm:aff id="aff5">Division of Infection and Immunity, University College London, London, UK</nlm:aff></affiliation><affiliation><nlm:aff id="aff6">NIHR Biomedical Research Centre, University College London Hospitals, London, UK</nlm:aff></affiliation></author><author><name sortKey="Heymann, David L" sort="Heymann, David L" uniqKey="Heymann D" first="David L" last="Heymann">David L. Heymann</name><affiliation><nlm:aff id="aff7">Centre on Global Health Security, Chatham House, London, UK</nlm:aff></affiliation><affiliation><nlm:aff id="aff8">Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK</nlm:aff></affiliation></author></analytic><series><title level="j">The Lancet. Respiratory Medicine</title><idno type="ISSN">2213-2600</idno><idno type="eISSN">2213-2619</idno><imprint><date when="2014">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><back><div1 type="bibliography"><listBibl><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Alagaili, An" uniqKey="Alagaili A">AN Alagaili</name></author><author><name sortKey="Briese, T" uniqKey="Briese T">T Briese</name></author><author><name sortKey="Mishra, N" uniqKey="Mishra N">N Mishra</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Institute Of Medicine Us Foum On Microbial Threats" uniqKey="Institute Of Medicine Us Foum On Microbial Threats">Institute of Medicine (US) Foum on Microbial Threats</name></author><author><name sortKey="Knobler, S" uniqKey="Knobler S">S Knobler</name></author><author><name sortKey="Mahmoud, A" uniqKey="Mahmoud A">A Mahmoud</name></author><author><name sortKey="Lemon, S" uniqKey="Lemon S">S Lemon</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Del Rio, C" uniqKey="Del Rio C">C Del Rio</name></author><author><name sortKey="Hernandez Avila, M" uniqKey="Hernandez Avila M">M Hernandez-Avila</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Butler, D" uniqKey="Butler D">D Butler</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Fraser, Dw" uniqKey="Fraser D">DW Fraser</name></author><author><name sortKey="Tsai, Tr" uniqKey="Tsai T">TR Tsai</name></author><author><name sortKey="Orenstein, W" uniqKey="Orenstein W">W Orenstein</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Steere, Ac" uniqKey="Steere A">AC Steere</name></author><author><name sortKey="Malawista, Se" uniqKey="Malawista S">SE Malawista</name></author><author><name sortKey="Snydman, Dr" uniqKey="Snydman D">DR Snydman</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Minggao Shen, Bw" uniqKey="Minggao Shen B">BW Minggao Shen</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct></listBibl></div1></back></TEI><pmc article-type="discussion"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Lancet Respir Med</journal-id><journal-id journal-id-type="iso-abbrev">Lancet Respir Med</journal-id><journal-title-group><journal-title>The Lancet. Respiratory Medicine</journal-title></journal-title-group><issn pub-type="ppub">2213-2600</issn><issn pub-type="epub">2213-2619</issn><publisher><publisher-name>Elsevier Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24794576</article-id><article-id pub-id-type="pmc">7129523</article-id><article-id pub-id-type="publisher-id">S2213-2600(14)70102-X</article-id><article-id pub-id-type="doi">10.1016/S2213-2600(14)70102-X</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Triumphs, trials, and tribulations of the global response to MERS coronavirus</article-title></title-group><contrib-group><contrib contrib-type="author" id="au10"><name><surname>McNabb</surname><given-names>Scott J N</given-names></name><email>scottjnmcnabb@emory.edu</email><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au20"><name><surname>Shaikh</surname><given-names>Affan T</given-names></name><xref rid="aff2" ref-type="aff">b</xref><xref rid="aff3" ref-type="aff">c</xref></contrib><contrib contrib-type="author" id="au30"><name><surname>Nuzzo</surname><given-names>Jennifer B</given-names></name><xref rid="aff4" ref-type="aff">d</xref></contrib><contrib contrib-type="author" id="au40"><name><surname>Zumla</surname><given-names>Alimuddin I</given-names></name><xref rid="aff5" ref-type="aff">e</xref><xref rid="aff6" ref-type="aff">f</xref></contrib><contrib contrib-type="author" id="au50"><name><surname>Heymann</surname><given-names>David L</given-names></name><xref rid="aff7" ref-type="aff">g</xref><xref rid="aff8" ref-type="aff">h</xref></contrib></contrib-group><aff id="aff1"><label>a</label>Rollins School of Public Health, Atlanta, GA 30322, USA</aff><aff id="aff2"><label>b</label>Public Health Practice, LLC, Atlanta, GA, USA</aff><aff id="aff3"><label>c</label>Ministry of Health, Riyadh, Saudi Arabia</aff><aff id="aff4"><label>d</label>UPMC Center for Health Security, Baltimore, MD, USA</aff><aff id="aff5"><label>e</label>Division of Infection and Immunity, University College London, London, UK</aff><aff id="aff6"><label>f</label>NIHR Biomedical Research Centre, University College London Hospitals, London, UK</aff><aff id="aff7"><label>g</label>Centre on Global Health Security, Chatham House, London, UK</aff><aff id="aff8"><label>h</label>Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK</aff><pub-date pub-type="pmc-release"><day>2</day><month>5</month><year>2014</year></pub-date><pmc-comment> PMC Release delay is 0 months and 0 days and was based on .</pmc-comment>
<pub-date pub-type="ppub"><month>6</month><year>2014</year></pub-date><pub-date pub-type="epub"><day>2</day><month>5</month><year>2014</year></pub-date><volume>2</volume><issue>6</issue><fpage>436</fpage><lpage>437</lpage><permissions><copyright-statement>Copyright © 2014 Elsevier Ltd. All rights reserved.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Elsevier Ltd</copyright-holder><license><license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p></license></permissions><related-article related-article-type="article-reference" id="d32e248" ext-link-type="doi" xlink:href="10.1016/S0140-6736(14)60732-7"></related-article></article-meta></front><body><p id="para10">22 months after its discovery, and despite extensive investigation and research, the source and origin of the Middle East Respiratory (MERS) coronavirus remain unknown.<xref rid="bib1" ref-type="bibr"><sup>1</sup></xref> As of April 26, 2014, 261 laboratory-confirmed cases of MERS coronavirus infection have been reported, including 93 deaths.<xref rid="bib2" ref-type="bibr"><sup>2</sup></xref> Although sustained human-to-human transmission has not been reported,<xref rid="bib1" ref-type="bibr"><sup>1</sup></xref> a global concern remains that the virus could become more contagious and deadly. An overabundance of caution is certainly prudent, but with the latest discovery—that the virus was documented in dromedary camels as long ago as 1992<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref>—interpretation of the epidemiology has become more difficult. Are the recently identified cases in Jordan, Qatar, the United Arab Emirates, and Saudi Arabia new, or a part of a long series of human disease? Improved collaboration between clinicians, scientists, and public health authorities will be necessary to understand the epidemiology and define the sources and modes of transmission.</p><p id="para20">Lessons from the SARS coronavirus outbreak<xref rid="bib4" ref-type="bibr"><sup>4</sup></xref> in 2003 and the influenza H1N1 pandemic<xref rid="bib5" ref-type="bibr"><sup>5</sup></xref> in 2009 suggest that effective, collaborative public health research in support of outbreak investigation and comprehensive risk management is encouraged by mutual respect—for others, authority, governance, information, and property (both intellectual and physical)—and a solid agreement. But the meaningful collaboration that helped the scientific community to rapidly identify the SARS coronavirus has not been seen recently. Collaborative research into MERS coronavirus has been scarce, with investigations marked by bitter disagreements between public health authorities and scientists about the virus' discovery and the ensuing publications, processes, and patenting of products.<xref rid="bib6" ref-type="bibr"><sup>6</sup></xref></p><p id="para30">The recent disagreements played out in the media raise several issues that should be addressed. Key among them is the absence of a consensus-built governance agreement for public health investigation and research when an event is recognised as a global public health emergency. Such an agreement would include the controversial issues of how to share animal and human specimens, investigational products (eg, pathogens and viral isolates), and intellectual property (eg, public health surveillance data and scientific publications). Without agreement about the mutually beneficial roles, responsibilities, and legitimate contributions of clinicians, scientists, and public health authorities, parties end up either encroaching on one another or not communicating—both of which are happening now with respect to MERS coronavirus.</p><p id="para40">Public health authorities and academic scientists must work together to discover and pursue investigation of emerging or re-emerging infectious diseases, and clinicians and scientists must fulfil their legal responsibility to report relevant data to public health authorities through official mechanisms. Such reporting enables public health authorities to undertake their legitimate and crucial role in investigating, preventing, and controlling future transmission. Successful examples of this delicate yet important balance include the recognition, reporting, and research around Legionnaires' disease<xref rid="bib7" ref-type="bibr"><sup>7</sup></xref> and Lyme disease<xref rid="bib8" ref-type="bibr"><sup>8</sup></xref>—outbreaks that were reported appropriately, while public health research ensued.</p><p id="para50">Four considerations are pertinent to an agreement: the immediate need to control the spread of disease by public health authorities; the intellectual curiosity of clinicians and scientists; the long-term commercial interests of the pharmaceutical industry; and the economic wellbeing of the farming and ranching communities. Governance should be built around One Health, an interdisciplinary collaboration between human and veterinarian medicine and health, because economic loss is an important consideration (as can be seen from the negative economic effect of the present influenza H7N9 outbreak<xref rid="bib9" ref-type="bibr"><sup>9</sup></xref>). Additional steps should be taken to protect the economic interests of farmers and livestock owners. Livestock insurance schemes, already used for protection against drought, could be used for reimbursement.<xref rid="bib10" ref-type="bibr"><sup>10</sup></xref> The development of a global biological risk management fund to share the burden of economic loss would enhance the mission of the 2005 International Health Regulations (IHRs).</p><p id="para60">The sovereign rights of IHR state parties must be respected. National ministries of health are responsible for the detection, assessment, reporting, and response to public health issues that threaten their populations. The willingness of states to collaborate on comprehensive risk assessments is dependent on the perception that doing so will not conflict with their own national self-interest; the global scientific community cannot force a country to collaborate. Unfortunately, the IHRs offer no guidance for how to collaborate in this way.</p><p id="para70">Strengthened global collaboration in public health research requires trust. And trust can only be built through the transparency embodied in clearly defined norms that govern how research products and data will be used and who owns them. Although the IHRs require states to share timely and accurate reports about public health emergencies of international concern, they do not specify in any practical detail other important features of data sharing and public health research collaboration, including ownership and access to patient specimens, research data, and scientific products (eg, diagnostics, vaccines, and medical countermeasures). The pandemic influenza preparedness framework<xref rid="bib11" ref-type="bibr"><sup>11</sup></xref> is a commendable start, but is limited in scope and does not provide guidance for data sharing for non-influenza viruses or other biological specimens. Recent discussions within the Convention on Biological Diversity in Nagoya, Japan,<xref rid="bib12" ref-type="bibr"><sup>12</sup></xref> are also a step forward with respect to the ownership of biological materials.</p><p id="para80">What is now required is for the public health and research communities to rally around the design and adoption of a consensus-built global governance agreement for rapid, effective collaborative investigation in the event of emerging infectious disease threats with pandemic potential. This process could occur through the amendment of the existing IHRs, with the addition of clear codes of practice for the sharing of public health surveillance data and other intellectual property and for the conduct of the collaborative epidemiological research necessary for comprehensive risk assessment.</p><p id="para90">Enhancement of the IHRs in this way would clearly define international expectations about how essential public health data and products that emerge should be managed, shared, and owned. Likewise, it would clarify how states should interact when crucial information for risk assessment is needed by the global health security community. Such a development would improve the state of global health security.</p><p id="para100"><fig id="f10"><graphic xlink:href="fx1"></graphic><permissions><copyright-statement>© 2014 Dr Gopal Murti/Science Photo Library</copyright-statement><copyright-year>2014</copyright-year><license><license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p></license></permissions></fig></p></body><back><ref-list id="bibl10"><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="other" id="sbref10"><person-group person-group-type="author"><collab>PLoS Currents</collab><collab>PLoS Pathogens</collab></person-group><article-title>State of knowledge on MERS-CoV. PLoS Speaking of Medicine, 2014</article-title><ext-link ext-link-type="uri" xlink:href="http://blogs.plos.org/speakingofmedicine/2014/01/17/state-knowledge-mers-cov/" id="interrefs10">http://blogs.plos.org/speakingofmedicine/2014/01/17/state-knowledge-mers-cov/</ext-link><comment>(accessed April 2, 2014).</comment></element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="other" id="sbref20"><person-group person-group-type="author"><collab>WHO</collab></person-group><article-title>MERS-CoV summary updates</article-title><ext-link ext-link-type="uri" xlink:href="http://www.who.int/csr/disease/coronavirus_infections/archive_updates/en/" id="interrefs20">http://www.who.int/csr/disease/coronavirus_infections/archive_updates/en/</ext-link><comment>(accessed April 28, 2014).</comment></element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="journal" id="sbref30"><person-group person-group-type="author"><name><surname>Alagaili</surname><given-names>AN</given-names></name><name><surname>Briese</surname><given-names>T</given-names></name><name><surname>Mishra</surname><given-names>N</given-names></name></person-group><article-title>Middle East Respiratory Syndrome coronavirus infection in dromedary camels in Saudi Arabia</article-title><source>mBio</source><volume>5</volume><year>2014</year><fpage>e00884</fpage><comment>e00814</comment><pub-id pub-id-type="pmid">24570370</pub-id></element-citation></ref><ref id="bib4"><label>4</label><element-citation publication-type="book" id="sbref40"><person-group person-group-type="editor"><name><surname>Institute of Medicine (US) Foum on Microbial Threats</surname></name><name><surname>Knobler</surname><given-names>S</given-names></name><name><surname>Mahmoud</surname><given-names>A</given-names></name><name><surname>Lemon</surname><given-names>S</given-names></name></person-group><source>Learning from SARS: preparing for the next disease outbreak—workshop summary</source><year>2004</year><publisher-name>National Academies Press</publisher-name><publisher-loc>Washington, DC</publisher-loc></element-citation></ref><ref id="bib5"><label>5</label><element-citation publication-type="journal" id="sbref50"><person-group person-group-type="author"><name><surname>Del Rio</surname><given-names>C</given-names></name><name><surname>Hernandez-Avila</surname><given-names>M</given-names></name></person-group><article-title>Lessons from previous influenza pandemics and from the Mexican response to the current influenza pandemic</article-title><source>Arch Med Res</source><volume>40</volume><year>2009</year><fpage>677</fpage><lpage>680</lpage><pub-id pub-id-type="pmid">20304256</pub-id></element-citation></ref><ref id="bib6"><label>6</label><element-citation publication-type="journal" id="sbref60"><person-group person-group-type="author"><name><surname>Butler</surname><given-names>D</given-names></name></person-group><article-title>Tensions linger over discovery of coronavirus</article-title><source>Nature News</source><year>Jan 14, 2013</year><ext-link ext-link-type="uri" xlink:href="http://www.nature.com/news/tensions-linger-over-discovery-of-coronavirus-1.12108" id="interrefs30">http://www.nature.com/news/tensions-linger-over-discovery-of-coronavirus-1.12108</ext-link><comment>(accessed April 5, 2014).</comment></element-citation></ref><ref id="bib7"><label>7</label><element-citation publication-type="journal" id="sbref70"><person-group person-group-type="author"><name><surname>Fraser</surname><given-names>DW</given-names></name><name><surname>Tsai</surname><given-names>TR</given-names></name><name><surname>Orenstein</surname><given-names>W</given-names></name></person-group><article-title>Legionnaires' disease: description of an epidemic of pneumonia</article-title><source>N Engl J Med</source><volume>297</volume><year>1977</year><fpage>1189</fpage><lpage>1197</lpage><pub-id pub-id-type="pmid">335244</pub-id></element-citation></ref><ref id="bib8"><label>8</label><element-citation publication-type="journal" id="sbref80"><person-group person-group-type="author"><name><surname>Steere</surname><given-names>AC</given-names></name><name><surname>Malawista</surname><given-names>SE</given-names></name><name><surname>Snydman</surname><given-names>DR</given-names></name></person-group><article-title>Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities</article-title><source>Arthritis Rheum</source><volume>20</volume><year>1977</year><fpage>7</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">836338</pub-id></element-citation></ref><ref id="bib9"><label>9</label><element-citation publication-type="book" id="sbref90"><person-group person-group-type="author"><name><surname>Minggao Shen</surname><given-names>BW</given-names></name></person-group><source>China equity strategy—avian flu H7N9 remains a risk</source><year>2013</year><publisher-name>CITI Research</publisher-name><publisher-loc>Beijing</publisher-loc></element-citation></ref><ref id="bib10"><label>10</label><element-citation publication-type="other" id="sbref100"><article-title>Economist.com. Livestock insurance in Kenya: no risk, no reward. Economist.com, 2014</article-title><ext-link ext-link-type="uri" xlink:href="http://www.economist.com/blogs/baobab/2014/04/livestock-insurance-kenya" id="interrefs40">http://www.economist.com/blogs/baobab/2014/04/livestock-insurance-kenya</ext-link><comment>(accessed April 10, 2014).</comment></element-citation></ref><ref id="bib11"><label>11</label><element-citation publication-type="book" id="sbref110"><person-group person-group-type="author"><collab>WHO</collab></person-group><source>Pandemic influenza preparedness framework for the sharing of influenza viruses and access to vaccines and other benefits</source><year>2011</year><publisher-name>World Health Organization</publisher-name><publisher-loc>Geneva</publisher-loc><ext-link ext-link-type="uri" xlink:href="http://whqlibdoc.who.int/publications/2011/9789241503082_eng.pdf?ua=1" id="interrefs50">http://whqlibdoc.who.int/publications/2011/9789241503082_eng.pdf?ua=1</ext-link><comment>(accessed April 5, 2014).</comment></element-citation></ref><ref id="bib12"><label>12</label><element-citation publication-type="other" id="sbref120"><person-group person-group-type="author"><collab>Convention on Biological Diversity</collab></person-group><article-title>The Nagoya Protocol on Access and Benefit-sharing</article-title><ext-link ext-link-type="uri" xlink:href="https://www.cbd.int/abs/" id="interrefs60">https://www.cbd.int/abs/</ext-link><comment>(accessed April 5, 2014).</comment></element-citation></ref></ref-list><ack><p>We declare that we have no competing interests.</p></ack></back></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000807 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000807 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé=
|texte=
}}
| This area was generated with Dilib version V0.6.33. |  |